Girolamo Del Monte
- Oncology top 10%
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
- Inflammatory Biomarkers in Disease Prognosis 2
- Cancer Research top 10%
- Internal Medicine top 10%
- Hematology top 10%
- Dermatology top 10%
-
- Angiogenesis and VEGF in Cancer 3
-
- Gastric Cancer Management and Outcomes 3
-
- Hepatocellular Carcinoma Treatment and Prognosis 2
-
- Adipokines, Inflammation, and Metabolic Diseases 2
-
- Cell Adhesion Molecules Research 2
Girolamo Del Monte
20 papers receiving 756 citations
Peers
Comparison fields: 5 of 94
- Oncology 365
- Cancer Research 172
- Internal Medicine 37
- Hematology 74
- Dermatology 54
Countries citing papers authored by Girolamo Del Monte
This map shows the geographic impact of Girolamo Del Monte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Girolamo Del Monte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Girolamo Del Monte more than expected).
Fields of papers citing papers by Girolamo Del Monte
This network shows the impact of papers produced by Girolamo Del Monte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Girolamo Del Monte. The network helps show where Girolamo Del Monte may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Girolamo Del Monte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 11 | |
| 2 | 2020 | 6 | |
| 3 | 2017 | 25 | |
| 4 | 2017 | 9 | |
| 5 | 2017 | 16 | |
| 6 | 2010 | 65 | |
| 7 | 2010 | 21 | |
| 8 | Caregiver distress in the early phases of cancer. | 2010 | 24 |
| 9 | 2009 | 29 | |
| 10 | Prognostic significance of serum adipokine levels in colorectal cancer patients. | 2009 | 58 |
| 11 | A novel K-ras mutation in colorectal cancer. A case report and literature review. | 2009 | 16 |
| 12 | Interleukin-2 inhalation therapy in renal cell cancer: a case report and review of the literature. | 2008 | 1 |
| 13 | Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. | 2007 | 53 |
| 14 | Non-steroidal anti-inflammatory drugs in cancer prevention and therapy. | 2007 | 34 |
| 15 | 2006 | 28 | |
| 16 | 2005 | 35 | |
| 17 | 2004 | 37 | |
| 18 | 2004 | 56 | |
| 19 | 2003 | 238 | |
| 20 | 2000 | 17 |
About Girolamo Del Monte
Girolamo Del Monte is a scholar working on Internal Medicine, Cancer Research and Immunology and Allergy, having authored 20 papers that have together received 779 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Angiogenesis and VEGF in Cancer (3 papers), Gastric Cancer Management and Outcomes (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Oncology (365 citations), Cancer Research (172 citations) and Internal Medicine (37 citations). Girolamo Del Monte has collaborated with scholars based in Italy, India and Malaysia. Frequent co-authors include Mario Roselli, Fiorella Guadagni, Patrizia Ferroni, Raffaele Palmirotta, Vincenzo Formica, Antonella Spila, Francesca Martini, Vittoria Maresca, Annamaria Biroccio and Carlo Leonetti. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.